M Ferrantino, S D Navaneethan, J A Sloand. Show Affiliations »
Abstract
Entities: Disease Species
Mesh: See more » Amikacin/administration & dosageAmikacin/therapeutic useAnti-Bacterial Agents/administration & dosageAnti-Bacterial Agents/therapeutic useCeftazidime/administration & dosageCeftazidime/therapeutic useDiagnosis, DifferentialGram-Negative Bacterial Infections/diagnosisGram-Negative Bacterial Infections/drug therapyGram-Negative Bacterial Infections/microbiologyHumansMaleMiddle AgedPantoea/drug effectsPantoea/isolation & purificationPeritoneal Dialysis, Continuous AmbulatoryPeritonitis/diagnosisPeritonitis/drug therapyPeritonitis/microbiologyTreatment OutcomeWounds and Injuries/microbiology
Substances: See more » Anti-Bacterial AgentsAmikacinCeftazidime
Year: 2008 PMID: 18556394
Source DB: PubMed Journal: Perit Dial Int ISSN: 0896-8608 Impact factor: 1.756